Dubinsky MC, Armuzzi A, Gecse KB, Ullman T, et al. Improvements in disease activity partially mediate the effect of tofacitinib treatment on generic and disease-specific health-related quality of life in patients with ulcerative colitis: data from the OCTAVE program. Dig Dis 2023 Jan 5. doi: 10.1159/000528788.
PMID: 36603566